Effectiveness of dasabuvir/ombitasvir/paritaprevir/ritonavir for hepatitis C virus in clinical practice: A population-based observational study.

Maya Leventer-RobertsAriel HammermanIlan BrufmanMoshe HoshenMarius BraunYaffa AshurNicky LiebermanRan Balicer

Published in: PloS one (2017)

Treatment with dasabuvir/ombitasvir/paritaprevir/ritonavir demonstrated a near universal effectiveness in achieving a sustained virological response among HCV patients in a large cohort.

Keyphrases

hepatitis c virus
human immunodeficiency virus
end stage renal disease
randomized controlled trial
clinical practice
antiretroviral therapy
systematic review
ejection fraction
chronic kidney disease
newly diagnosed
hiv infected
combination therapy
patient reported